Prevention of distal flap necrosis in a rat random skin flap model by gene electrotransfer delivering VEGF165 plasmid

Journal of Gene Medicine

Volumn 16, Issue 3-4, 2014, Pages 55-65

  Basu, Gaurav ^a   Downey, Harre ^a   Guo, Siqi ^a   Israel, Annelise ^a   Asmar, Anthony ^a   Hargrave, Barbara ^a,b   Heller, Richard ^a,b  

^a OLD DOMINION UNIVERSITY   (United States)

^b OLD DOMINION UNIVERSITY   (United States)

Author keywords

Angiogenesis; Electrotransfer; Multi electrode array; Nonviral gene delivery; Random skin flap; Wound healing

Indexed keywords

CARPROFEN; VASCULOTROPIN 165; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISTAL FLAP NECROSIS; ELECTROPORATION; GRAFT SURVIVAL; HISTOLOGY; MALE; MULTI ELECTRODE ARRAY; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; RAT; SKIN FLAP; SURVIVAL RATE; TISSUE INJURY; TISSUE NECROSIS; WOUND HEALING; ANIMAL; ELECTRODE; GENE TRANSFER; GENETICS; NECROSIS; PATHOLOGY; SPRAGUE DAWLEY RAT; SURGICAL FLAPS;

ANIMALS; ELECTRODES; ELECTROPORATION; GENE TRANSFER TECHNIQUES; MALE; NECROSIS; PLASMIDS; RATS, SPRAGUE-DAWLEY; SURGICAL FLAPS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 84900432877     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.2759     Document Type: Article

References (44)

1. Milton SH. Pedicled skin-flaps: the fallacy of the length: width ratio. Br J Surg 1970; 57: 502-508.
2. McGregor IA, Morgan G. Axial and random pattern flaps. Br J Plast Surg 1973; 26: 202-213.
3. Kerrigan CL. Skin flap failure: pathophysiology. Plast Reconstr Surg 1983; 72: 766-777.
4. Myers MB, Cherry G. Causes of necrosis in pedicle flaps. Plast Reconstr Surg 1968; 42: 43-50.
5. Hockel M, Schlenger K, Doctrow S, Kissel T, Vaupel P. Therapeutic angiogenesis. Arch Surg 1993; 128: 423-429.
6. Plouet J, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 1989; 8: 3801-3806.
7. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-858.
8. Alon T, Hemo I, Itin A, et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat Med 1995; 1: 1024-1028.
9. Hippenstiel S, Krull M, Ikemann A, et al. VEGF induces hyperpermeability by a direct action on endothelial cells. Am J Physiol 1998; 274: L678-684.
10. Yuan F, Chen Y, Dellian M, et al. Time-dependent vascular regression and permeability changes in established human tumour xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody. Proc Natl Acad Sci U S A 1996; 93: 14765-14770.
11. Houck KA, Ferrara N, Winer J, et al. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991; 5: 1806-1814.
12. Carmeliet P. VEGF gene therapy: stimulating angiogenesis or angioma-genesis? Nat Med 2000; 6: 1102-1103.
13. Lee RJ, Springer ML, Blanco-Bose WE, et al. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Circulation 2000; 102: 898-901.
14. Ozawa CR, Banfi A, Glazer NL, et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 2004; 113: 516-527.
15. von Degenfeld G, Banfi A, Springer ML, et al. Microenvironmental VEGF distribution is critical for stable and functional vessel growth in ischemia. FASEB J 2006; 20: 2657-2659.
16. Dor Y, Djonov V, Keshet E. Induction of vascular networks in adult organs: implications to proangiogenic therapy. Ann NY Acad Sci 2003; 995: 208-216.
17. Kryger Z, Zhang F, Dogan T, et al. The effects of VEGF on survival of a random flap in the rat: examination of various routes of administration. Br J Plast Surg 2000; 53: 234-239.
18. Liu PY, Tong W, Liu K, et al. Liposome-mediated transfer of vascular endothelial growth factor cDNA augments survival of random-pattern skin flaps in the rat. Wound Repair Regen 2004; 12: 80-85.
19. Giunta RE, Holzbach T, Taskov C, et al. AdVEGF165 gene transfer increases survival in overdimensioned skin flaps. J Gene Med 2005; 7: 297-306.
20. Deodato B, Arsic N, Zentilin L, et al. Recombinant AAV vector encoding human VEGF165 enhances wound healing. Gene Ther 2002; 9: 777-785.
21. Yoon CS, Jung HS, Kwon MJ, et al. Sonoporation of the minicircle-VEGF(165) for wound healing of diabetic mice. Pharm Res 2009; 26: 794-801.
22. Ferraro B, Cruz YL, Coppola D, Heller R. Intradermal delivery of plasmid VEGF(165) by electroporation promotes wound healing. Mol Ther 2009; 17: 651-657.
23. Marti GP, Mohebi P, Liu L, et al. KGF-1 for wound healing in animal models. Methods Mol Biol 2008; 423: 383-391.
24. Liu L, Marti GP, Wei X, et al. Age-dependent impairment of HIF-1alpha expression in diabetic mice: correction with electroporation-facilitated gene therapy increases wound healing, angiogenesis, and circulating angiogenic cells. J Cell Physiol 2008; 217: 319-327.
25. Guo S, Donate A, Basu G, et al. Electro-gene transfer to skin using a noninvasive multielectrode array. J Control Release 2011; 151: 256-262.
26. Ferraro B, Heller LC, Cruz YL, et al. Evaluation of delivery conditions for cutaneous plasmid electrotransfer using a multielectrode array. Gene Ther 2011; 18: 496-500.
27. McFarlane RM, Deyoung G, Henry RA. The design of a pedicle flap in the rat to study necrosis and its prevention. Plast Reconstr Surg 1965; 35: 177-182.
28. Heller R, Cruz Y, Heller LC, Gilbert RA, Jaroszeski MJ. Electrically mediated delivery of plasmid DNA to the skin, using a multielectrode array. Hum Gene Ther 2010; 21: 357-362.
29. Zachary I. Vascular endothelial growth factor. Int J Biochem Cell Biol 1998; 30: 1169-1174.
30. Nissen NN, Polverini PJ, Koch AE, et al. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing. Am J Pathol 1998; 152: 1445-1452.
31. Taub PJ, Marmur JD, Zhang WX, et al. Effect of time on the viability of ischemic skin flaps treated with vascular endothelial growth factor (VEGF) cDNA. J Reconstr Microsurg 1998; 14: 387-390.
32. Byrnes CK, Khan FH, Nass PH, et al. Success and limitations of a naked plasmid transfection protocol for keratinocyte growth factor-1 to enhance cutaneous wound healing. Wound Repair Regen 2001; 9: 341-346.
33. Yla-Herttuala S, Alitalo K. Gene transfer as a tool to induce therapeutic vascular growth. Nat Med 2003; 9: 694-701.
34. Muruve DA, Barnes MJ, Stillman IE, Libermann TA. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum Gene Ther 1999; 10: 965-976.
35. Masaki I, Yonemitsu Y, Yamashita A, et al. Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Circ Res 2002; 90: 966-973.
36. Khan TA, Sellke FW, Laham RJ. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia. Gene Ther 2003; 10: 285-291.
37. Vincent KA, Jiang C, Boltje I, Kelly RA. Gene therapy progress and prospects: therapeutic angiogenesis for ischemic cardiovascular disease. Gene Ther 2007; 14: 781-789.
38. Marti G, Ferguson M, Wang J, et al. Electroporative transfection with KGF-1 DNA improves wound healing in a diabetic mouse model. Gene Ther 2004; 11: 1780-1785.
39. Lee PY, Chesnoy S, Huang L. Electroporatic delivery of TGF-beta1 gene works synergistically with electric therapy to enhance diabetic wound healing in db/db mice. J Invest Dermatol 2004; 123: 791-798.
40. Ferraro B, Cruz YL, Baldwin M, Coppola D, Heller R. Increased perfusion and angiogenesis in a hindlimb ischemia model with plasmid FGF-2 delivered by noninvasive electroporation. Gene Ther 2010; 17: 763-769.
41. Donate A, Coppola D, Cruz Y, Heller R. Evaluation of a novel non-penetrating electrode for use in DNA vaccination. PLoS One 2011; 6: e19181.
42. Dafni H, Landsman L, Schechter B, Kohen F, Neeman M. MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor. NMR Biomed 2002; 15: 120-131.
43. Pang Y, Lineaweaver WC, Lei MP, et al. Evaluation of the mechanism of vascular endothelial growth factor improvement of ischemic flap survival in rats. Plast Reconstr Surg 2003; 112: 556-564.
44. Um SC, Suzuki S, Toyokuni S, et al. Involvement of nitric oxide in survival of random pattern skin flap. Plast Reconstr Surg 1998; 101: 785-792.